XORTX to focus on late stage allopurinol intolerant gout program; discussion with FDA planned for first half 2025 regarding ...

XORTX Therapeutics (XRTX) announces the launch of a new late stage program to treat gout. The new drug development program – XRx-026 – will ...

First Amendment: Congress shall make no law respecting an establishment of religion, or prohibiting the free exercise thereof; or abridging the freedom of speech, or of the press; or the right of the ...

The following is a summary of “Improving Gout Care in a Canadian Academic Medical Center Through a Multidisciplinary ...

XORTX Therapeutics Inc. is a late-stage clinical pharmaceutical company focused on developing innovative therapies to treat progressive kidney disease. The company is actively involved in creating ...

Attacks may be polyarticular and can intensify quickly. Colchicine in combination with probenecid or allopurinol is frequently used to treat gouty flares. [22] For acute attacks refractory to or ...

Zyloprim (allopurinol) Amoxicillin is an antibiotic that can be an effective treatment option for UTIs depending on the bacteria causing the infection. It helps to relieve UTI symptoms by ...

Gout flares among adults in the United States are significantly underreported to healthcare providers, with nearly 72% of flares either not reported or pretreated/prevented by patients, according to ...

Arthritis Care Research News Alerts. 2007;57(5):816-821. High uric acid levels in the blood are a precursor of gout, the most common inflammatory arthritis in adult men. It is believed that coffee ...

Get all the US Food and Drug Administration breaking news updates, videos, photostories and more at Business Standard.

OBJECTIVES To study the efficacy of allopurinol and benzbromarone to reduce serum urate concentrations in patients with primary chronic gout. METHODS Prospective, parallel, open study of 86 ...